Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 USD | +1.73% | +8.75% | +95.52% |
Mar. 22 | Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target | MT |
Mar. 18 | Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company is in a robust financial situation considering its net cash and margin position.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.23 for the 2024 fiscal year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+95.52% | 4.04B | - | ||
+13.21% | 9.89B | B- | ||
+1.97% | 6.49B | C+ | ||
+2.30% | 2.38B | B+ | ||
-23.73% | 1B | C | ||
+4.60% | 890M | - | D+ | |
+85.42% | 767M | - | C | |
+7.80% | 164M | - | - | |
-8.15% | 69.15M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- OSCR Stock
- Ratings Oscar Health, Inc.